GIC-1114/1114m

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGIC-1114/1114m

Drug Alias NameCOVID-19 vaccine (GI-Cell/GI-Innovation/International Vaccine Institute)multivalent protein subunit using GI-COV-VAX (GI-Cell/GI-Innovation/International Vaccine Institute)GI-COV-VAX

ClassificationVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGi Cell Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesInternational Vaccine Institute Gi Cell Inc

Active IndicationsN/A

Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A